Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan

NCT01004159 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped former PI left institute

Conditions

Colorectal Cancer

Interventions

DRUG: cetuximab with irinotecan

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]